Efficacy of recombinant human brain natriuretic peptide as an adjuvant therapy for severe heart failure, and its impact on oxidative stress and quality of life in patients
Y Zeng, W Ma, H Xue, C Ma, Y Wang, X Ren… - Tropical Journal of …, 2023 - ajol.info
Purpose: To evaluate the efficacy of recombinant human brain natriuretic peptide as an
adjuvant therapy for severe heart failure, and its effect on oxidative stress and quality of life …
adjuvant therapy for severe heart failure, and its effect on oxidative stress and quality of life …
Investigating Infection-Related Hospitalization as a Risk Factor for Incident Heart Failure and Mortality among Heart Failure Patients
R Molinsky - 2023 - conservancy.umn.edu
HF is a growing epidemic with an estimated prevalence of 6.5 million individuals in the US,
and poor outcomes persist despite recent therapeutic advancements. Studies have shown …
and poor outcomes persist despite recent therapeutic advancements. Studies have shown …
Investigating Infection-Related Hospitalization as a Risk Factor for Incident Heart and Mortality Among Heart Failure Patients
RL Molinsky - 2023 - search.proquest.com
HF is a growing epidemic with an estimated prevalence of 6.5 million individuals in the US,
and poor outcomes persist despite recent therapeutic advancements. Studies have shown …
and poor outcomes persist despite recent therapeutic advancements. Studies have shown …
Interleukin-1 and Eosinophils in Heart Failure
M Golino - 2023 - irinsubria.uninsubria.it
Background. Anakinra, an IL-1 inhibitor, temporarily increases eosinophil blood levels in
patients with acute myocardial infarction and reduces heart failure (HF) events. Anakinra is …
patients with acute myocardial infarction and reduces heart failure (HF) events. Anakinra is …
Circulating cell-derived extracellular vesicles and epigenetic small non-coding ribonucleic acids in chronic heart failure
A Vilella Figuerola - 2023 - ddd.uab.cat
Introducció: La insuficiència cardíaca (IC) és una entitat complexa d'alt impacte clínic i
fisiopatologia poc coneguda. És una patologia difícil de reconèixer i de diagnosticar …
fisiopatologia poc coneguda. És una patologia difícil de reconèixer i de diagnosticar …
Identification the hub genes of immune cells related to heart failure by WGCNA
Y Lv, P Chen - 2023 - researchsquare.com
Objective To search the potential diagnostic markers of heart failure and analyze the
correlation between them and immune cell infiltration by WGCNA. Methods The expression …
correlation between them and immune cell infiltration by WGCNA. Methods The expression …
Evolución de las subpoblaciones de monocitos circulantes en pacientes con insuficiencia cardíaca que mejoran la fracción de eyección
A Grande Trillo - 2023 - idus.us.es
Introducción. Tras debutar con insuficiencia cardíaca con fracción de eyección reducida
(ICFEr) se instaura tratamiento de bloqueo neurohormonal con el que un subgrupo de …
(ICFEr) se instaura tratamiento de bloqueo neurohormonal con el que un subgrupo de …
The role and mechanism of NLRP3 inflammasome in chronic heart failure
W Gan, Z Jianghua - J Clin Cardiol, 2023 - lcxxgen.whuhzzs.com
Chronic heart failure (CHF) is the terminal stage of cardiovascular disease. Although the
treatment of CHF has been continuously improved in recent years, there are still high …
treatment of CHF has been continuously improved in recent years, there are still high …
ПРОФИЛЬ МОЛЕКУЛЯРНЫХ МАРКЕРОВ ФИБРОЗА У КРЫС ПРИ ВОЗДЕЙСТВИИ РАЗЛИЧНЫХ ДОЗ ДОКСОРУБИЦИНА
ЕЮ Подъячева, ТВ Шмакова, ДД Андреева… - Журнал …, 2023 - rusjphysiol.org
Аннотация Работа посвящена исследованию профиля молекулярных маркеров
фиброза при введении крысам стока Wistar различных доз доксорубицина. Работа …
фиброза при введении крысам стока Wistar различных доз доксорубицина. Работа …
The new face of HFpEF: systemic inflammation
M Lelonek - Folia Cardiologica, 2023 - journals.viamedica.pl
Systemic inflammation is proposed as background of development and progres of heart
failure, especially in heart failure with preserved ejection fraction (HFpEF). High-sensitivity C …
failure, especially in heart failure with preserved ejection fraction (HFpEF). High-sensitivity C …